Engineered red blood cells impersonate normal ones, and have new capacities Kumar Jeetendra | June 4, 2020 Researchers have attempted to create manufactured red platelets that copy the ideal properties of common ones, for example, adaptability, oxygen transport and long course times. Be that as it may, up until now, most counterfeit red platelets have had one or a couple, yet not every single, key element of the characteristic renditions. Presently, scientists …
Seeing how the malaria can withstand fever’s warmth Kumar Jeetendra | October 6, 2020 Even when a man suffering from malaria is burning up with fever and too ill to operate, the little blood-eating parasites lurking inside them continue to flourish, relentlessly growing and multiplying as they gobble up the host’s red blood cells. The single-celled Plasmodium parasites that cause 200 million cases of malaria annually can withstand feverish …
Mosquito protein study could prompt therapeutics against dangerous viruses Kumar Jeetendra | March 11, 2021 The researchers found that AEG12 works by destabilizing the viral envelope, breaking its protective covering. Although the protein doesn’t affect viruses that don’t have an envelope, such as the ones that cause pink eye and bladder ailments, the findings could lead to therapeutics against viruses which affect millions of people around the world. The research …
Drug-discovery collaboration discovers potential new antimalarial drug candidates Kumar Jeetendra | April 23, 2021 Potential new antimalarial drug candidates are being developed through an protracted drug-discovery collaboration between Australian medical research institute WEHI and Janssen Pharmaceutica NV. The collaboration was facilitated by Johnson & Johnson Innovation. A collaborative research team discovered compounds with antimalarial activity within a collection of 80,000 drug-like molecules at the Janssen Jump-stARter Compound Library, a …
New medication like compound could adequately hinder a critical step in malaria parasite life cycle Kumar Jeetendra | May 19, 2021 Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a vital step in the malaria parasite life cycle and are working to develop this compound into a potential first of its type malaria treatment. While drugs and mosquito control have reduced levels of …